Skip to main content
Premium Trial:

Request an Annual Quote

Isogen to Distribute Axela Platforms

NEW YORK (GenomeWeb News) – Isogen Life Science will distribute Axela's multiplex biomarker platforms in Benelux and Spain under an agreement announced by the firms today.

Isogen, based in De Meern, The Netherlands, will manage sales and support of Axela's flow through systems to clinical research markets in the designated countries. Platforms covered by the deal include Axela's Ziplex Research System for gene and protein microarray analysis, the dotLab mX System for real-time multiplex immunoassays, and the panelPlus technology for creating custom multiplex panels for biomarker analysis.

Financial and other terms of the alliance were not disclosed.

"The Ziplex and dotLab mX product range nicely complement our portfolio of distributed and internally developed products for life science research markets," Isogen Managing Director Hans Beijersbergen van Henegouwen said in a statement. "Working closely with the Axela team, we will be able to provide our customers with robust, time-saving solutions for their biomarker discovery and validation projects."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.